Arch Biopartners Receives Central IRB Approval to Support U.S. Sites in Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial of LSALT Peptide

Keyword: Cardiac Surgery

Publisher: Financial Post

Published: Aug 31, 2026

These assets represent distinct, mechanism-based approaches focused on protecting the kidney from common causes of acute and chronic damage. Chronic kidney disease affects more than 800 million peopl… [+2937 chars]

Read Full Story ↗